What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, dilated cardiomyopathy study

Journal of the National Medical Association

Volumn 89, Issue 4, 1997, Pages 277-282

  Coughlin, Steven S ^a,b   Myers, Leann ^a   Michaels, Robert K ^a  

^a TULANE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Blacks; Dilated cardiomyopathy; Socioeconomic status; Survival

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; ETHNOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; SOCIOECONOMICS; SURVIVAL RATE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, DILATED; DISTRICT OF COLUMBIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 0031109866     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gillum RF. Idiopathic cardiomyopathy in the United States. Am Heart J. 1986;111:752-755.
2. Coughlin SS, Szklo M, Baughman K, Pearson TA. The epidemiology of idiopathic dilated cardiomyopathy in a biracial community. Am J Epidemiol. 1990;131:48-56.
3. Coughlin SS, Labenberg JR, Tefft MC. Black-white differences in idiopathic dilated cardiomyopathy: the Washington, DC Dilated Cardiomyopathy Study. Epidemiology. 1993;4:165-172.
4. Coughlin SS, Gottdiener JS, Baughman KL, Wasserman A, Marx ES, Tefft MC, et al. Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study. J Natl Med Assoc. 1994;86:583-591.
5. Romeo F, Pelliccia F, Cianfrocca C, Cristofani R, Reale A. Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;63:138-140.
6. Diaz RA, Obasohan A, Oakley CM. Prediction of outcome in dilated cardiomyopathy. British Heart Journal. 1987;58:393-399.
7. Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, Gersh BJ. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med. 1992;117:117-123.
8. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525-531.
9. Ciaccheri M, Castelli G, Cecchi F, Nannini M, Santoro G, Troiani V, et al. Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. British Heart Journal. 1989;62:26-29.
10. Komajda M, Jais JP, Reeves F, Goldfarb B, Bouhour JB, Juillieres Y, et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 1990;11:824-831.
11. Kuroda T, Shiina A, Suzuki O, Fujita T, Noda T, Tsuchiya M, et al. Prediction of prognosis of patients with idiopathic dilated cardiomyopathy: a comparison of echocardiography with cardiac catheterization. Jpn J Med. 1989;28:180-188.
12. Segal JP, Stapleton JF, McClellan JR, Waller BF, Harvey WP. Idiopathic cardiomyopathy: clinical features, prognosis and therapy. Curr Probl Cardiol. 1978;3:1-49.
13. Kuhn H, Breithardt G, Knieriem HJ, Kohler E, Losse B, Seipel L, et al. Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med. 1978;54:451-459.
14. Toshima H. Research on cardiomyopathy in Japan. Heart Vessels. 1985;1(suppl):14-17.
15. Coughlin SS, Pearle DL, Baughman KL, Wasserman A, Tefft MC. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy: The Washington, DC, Dilated Cardiomyopathy Study. Ann Epidemiol. 1994;4:67-74.
16. Criqui MH, Wallace RB, Mishkel M, Barrett-Connor E, Heiss G. Alcohol consumption and blood pressure: the Lipid Research Clinics Prevalence Study. Hypertension. 1981;3:557-565.
17. Lee ET. Statistical Methods for Survival Data Analysis. Belmont, Calif: Lifetime Learning Publications; 1980.
18. Cox DR. Regression models and life tables (with discussion). Journal of the Royal Statistical Society Series B. 1972;34:187.
19. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the 1-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984;54:147-152.
20. Cleland J, Dargie H, Ford I. Mortality in heart failure: clinical variables of prognostic value. British Heart Journal 1987;58:572-582.
21. Gavazzi A, De Maria R, Renosto G, Moro A, Borgia M, Caroli A, et al. The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. Am Heart J. 1993;125:410-422.
22. Camerini F, Bussani R, Lenarda D, Lardieri G, Mestroni L, Miani D, et al. Clinical aspects and haemodynamics in the follow-up of dilated cardiomyopathy and myocarditis. Eur Heart J. 1991;12(suppl D):193-196.
23. Olshausen KV, Stienen U, Schwarz F, Kübler W, Meyer J. Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1988;61:146-151.
24. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564-1575.
25. Kopecky SL, Gersh BJ. Dilated cardiomyopathy and myocarditis: Natural history, etiology, clinical manifestations, and management. Curr Probl Cardiol. 1987;12:569-647.
26. Coughlin SS, Metayer C, McCarthy EP, Mather FJ, Waldhorn RE, Gersch BJ, et al. Respiratory illness, β-agonists, and risk of idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study. Am J Epidemiol. 1995;142:395-403.